Latest oppositions filed by Hexal Ag

This table presents recent patent oppositions filed by Hexal Ag against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3250191Tablets Comprising Glp-1 Agonist And Enteric CoatingNOVO NORDISK A/SOct 17, 2024
EP3542790Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISK A/SJun 13, 2024
EP3746111Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A LubricantNOVO NORDISK A/SApr 19, 2024
EP3488857Compositions Of Glp-1 Peptides And Preparation ThereofNOVO NORDISK A/SMar 7, 2024
EP3000467Treatment Regimen Utilizing Neratinib For Breast CancerWYETH LLCNov 3, 2023
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MA INC.Jul 21, 2022
EP3401335Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants ThereofGENENTECH, INC.Nov 8, 2021
EP3311374Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques ThereforJANSSEN PHARMACEUTICA NVApr 22, 2021
EP3241550(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsGRÜNENTHAL GMBHApr 20, 2021
EP3280416Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS, INC.Jan 21, 2021

The following table provides an overview of the latest patents of Hexal Ag that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2909632Nov 24, 2021Improved Method Of Mapping Glycans Of Glycoproteins1
EP3196646Dec 18, 2019Methods Of Mapping Protein Variants1